Stockreport

Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference

Immuneering Corporation - Class A  (IMRX) 
PDF NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive an [Read more]